Quibim Earns FDA Clearance for Prostate MRI Solution

Quibim has received FDA 510(k) clearance for qp-Prostate, an artificial intelligence-based magnetic resonance imaging (MRI) solution for analyzing the prostate.

The non-invasive solution assists in visualizing and quantifying the prostate to potentially help detect prostate cancer early on in patients.

The Valencia, Spain-based company said qp-Prostate is the only technology available that offers automatic regional organ segmentation that can help reduce interpretation time by identifying and segmenting each prostate region.